Glycyrrhizin

Research published in The Lancet found glycyrrhizin is a powerful inhibitor of SARS and related coronaviruses. Glycyrrhizin supports the generation of healthy mucus in the lungs. All glycyrrhizin findings are based on in-vitro laboratory research, not clinical human trials. Glycyrrhizin decreases the ability of the virus to penetrate inside the host cell. Glycyrrhizin increases T-cell activity, supporting the adaptive immune response. Glycyrrhizin is a phytonutrient extracted from black licorice root. Glycyrrhizin has shown antiviral research interest against hepatitis C virus and HIV, beyond coronavirus activity.